Alibaba tells vendors to halt drug sales online, cites government rule change

An employee is seen behind a glass wall with the logo of Alibaba at the company's headquarters on the outskirts of Hangzhou, Zhejiang provinceChinese e-commerce firm Alibaba Group Holding Ltd has told vendors on its Tmall website to stop selling medicine, saying a local regulator has issued an "urgent" directive halting drug sales via third-party platforms. Alibaba, in a notice dated May 27 seen by Reuters, cited a circular from the Hebei province branch of the China Food and Drug Administration (CFDA) on "urgent control measures relating to drug products". The regulator&;s surprise directive comes as the government promotes retail sales of over-the-counter (OTC) medicine, with a pledge to harness technology to solve issues as varied as high drug prices and snarling hospital queues.

Go to Source

Sleep Revolution in the Summertime

The Swoosh, Then and NowImage of me showing off my Somni face mask from my Sleep Revolution gift bag. Photo by Milton Dimas. After a stressful school year, all college students want to come home and relax. I know; I am no different. Since being home I&;ve admittedly watched hours of TV, and binged on Buzzfeed or Tasty videos late into the night. Without all the…

Go to Source

G7 told to act on antibiotics as dreaded superbug hits U.S.

Colonies of E. coli bacteria are seen in a microscopic image courtesy of the CDCBy Kylie MacLellan and Ben Hirschler ISE-SHIMA, Japan/LONDON (Reuters) – Britain told the G7 industrial powers on Friday to do more to fight killer superbugs as the United States reported the first case in the country of a patient with bacteria resistant to a last-resort antibiotic. U.S. scientists said the infection in a 49-year-old Pennsylvania woman "heralds the emergence of truly pan-drug resistant bacteria" because it could not be controlled even by colistin, an antibiotic reserved for "nightmare" bugs. In Japan, British Prime Minister David Cameron said leading countries needed to tackle resistance by reducing the use of antibiotics and rewarding drug companies for developing new medicines.

Go to Source

1 72 73 74 75 76 125